Get Social With Us

Concerns, Collaboration, and Capacity: A Biosimilars Roundtable at the 2013 BIO International Convention

By: BioProcess International
Reprinted with the permission of BioProcess International BioProcess International, June 2013

In the June 2013 Supplement, BioProcess International transcribed and printed a roundtable discussion led by Patti Seymour, Senior Consultant, at the BIO International Convention in which she comments on the implications of FDA’s draft guidance documents on biosimilars development.